The GLP1 agonist treatment leads to an improvement of glycemic control and areduction in body weight. Liraglutide may be used in adolescents from the age of 10years onwards in combination with metformin or exclusively in cases of metformin intolerance. Further studies with GLP1 analogues are being...
The invention relates to novel polypeptide analogues of GLP-1 and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. Preferably, the polypetide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP-1 or extenidn-4....
DDP‐IV‐Inhibitoren und GLP‐1‐AnalogaNo abstract is available for this article.doi:10.1002/pauz.201090012WILEY‐VCH VerlagPharmazie in Unserer Zeit
Glucagon-like-peptide-2- (glp-2-) analoga Glucagon-like peptide-2- (glp-2) analoguesBjarne Due LarsenYvette Miata PetersenKirsten Ebbehoej